154 related articles for article (PubMed ID: 29296786)
1. ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model.
Greineder CF; Johnston IH; Villa CH; Gollomp K; Esmon CT; Cines DB; Poncz M; Muzykantov VR
Blood Adv; 2017 Aug; 1(18):1452-1465. PubMed ID: 29296786
[TBL] [Abstract][Full Text] [Related]
2. Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation.
Ding BS; Hong N; Christofidou-Solomidou M; Gottstein C; Albelda SM; Cines DB; Fisher AB; Muzykantov VR
Am J Respir Crit Care Med; 2009 Aug; 180(3):247-56. PubMed ID: 19342415
[TBL] [Abstract][Full Text] [Related]
3. Biocompatible coupling of therapeutic fusion proteins to human erythrocytes.
Villa CH; Pan DC; Johnston IH; Greineder CF; Walsh LR; Hood ED; Cines DB; Poncz M; Siegel DL; Muzykantov VR
Blood Adv; 2018 Feb; 2(3):165-176. PubMed ID: 29365311
[TBL] [Abstract][Full Text] [Related]
4. Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor.
Greineder CF; Chacko AM; Zaytsev S; Zern BJ; Carnemolla R; Hood ED; Han J; Ding BS; Esmon CT; Muzykantov VR
PLoS One; 2013; 8(11):e80110. PubMed ID: 24244621
[TBL] [Abstract][Full Text] [Related]
5. Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.
Carnemolla R; Villa CH; Greineder CF; Zaitsev S; Patel KR; Kowalska MA; Atochin DN; Cines DB; Siegel DL; Esmon CT; Muzykantov VR
FASEB J; 2017 Feb; 31(2):761-770. PubMed ID: 27836986
[TBL] [Abstract][Full Text] [Related]
6. Platelet endothelial cell adhesion molecule targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and in vivo.
Carnemolla R; Greineder CF; Chacko AM; Patel KR; Ding BS; Zaitsev S; Esmon CT; Muzykantov VR
J Pharmacol Exp Ther; 2013 Nov; 347(2):339-45. PubMed ID: 23965383
[TBL] [Abstract][Full Text] [Related]
7. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
8. Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis.
Zaitsev S; Kowalska MA; Neyman M; Carnemolla R; Tliba S; Ding BS; Stonestrom A; Spitzer D; Atkinson JP; Poncz M; Cines DB; Esmon CT; Muzykantov VR
Blood; 2012 May; 119(20):4779-85. PubMed ID: 22493296
[TBL] [Abstract][Full Text] [Related]
9. Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo.
Kiseleva RY; Glassman PG; LeForte KM; Walsh LR; Villa CH; Shuvaev VV; Myerson JW; Aprelev PA; Marcos-Contreras OA; Muzykantov VR; Greineder CF
FASEB J; 2020 Sep; 34(9):11577-11593. PubMed ID: 32738178
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell activation in cutaneous vasculitis.
Jurd KM; Stephens CJ; Black MM; Hunt BJ
Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
[TBL] [Abstract][Full Text] [Related]
11. Recombinant lectin-like domain of thrombomodulin suppresses vascular inflammation by reducing leukocyte recruitment via interacting with Lewis Y on endothelial cells.
Lin WL; Chang CF; Shi CS; Shi GY; Wu HL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2366-73. PubMed ID: 23950139
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect.
Greineder CF; Brenza JB; Carnemolla R; Zaitsev S; Hood ED; Pan DC; Ding BS; Esmon CT; Chacko AM; Muzykantov VR
FASEB J; 2015 Aug; 29(8):3483-92. PubMed ID: 25953848
[TBL] [Abstract][Full Text] [Related]
13. Effects of human soluble thrombomodulin on experimental glomerulonephritis.
Ikeguchi H; Maruyama S; Morita Y; Fujita Y; Kato T; Natori Y; Akatsu H; Campbell W; Okada N; Okada H; Yuzawa Y; Matsuo S
Kidney Int; 2002 Feb; 61(2):490-501. PubMed ID: 11849389
[TBL] [Abstract][Full Text] [Related]
14. Functional difference between membrane-bound and soluble human thrombomodulin.
Miwa Y; Yazaki S; Iwamoto M; Suzuki S; Iwasaki K; Haneda M; Yamamoto K; Maruyama S; Onishi A; Kobayashi T
Transplantation; 2015 Apr; 99(4):702-9. PubMed ID: 25643141
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor induces ICAM-1and thrombomobulin expression in vitro.
Shyu LY; Yeh TM; Chang HH; Lin DP; Teng YH; Chen LC; Lee HH
Thromb Res; 2012 Jan; 129(1):43-9. PubMed ID: 21890178
[TBL] [Abstract][Full Text] [Related]
16. Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation.
Miwa Y; Yamamoto K; Onishi A; Iwamoto M; Yazaki S; Haneda M; Iwasaki K; Liu D; Ogawa H; Nagasaka T; Uchida K; Nakao A; Kadomatsu K; Kobayashi T
Xenotransplantation; 2010; 17(1):26-37. PubMed ID: 20149186
[TBL] [Abstract][Full Text] [Related]
17. Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration.
Christofidou-Solomidou M; Kennel S; Scherpereel A; Wiewrodt R; Solomides CC; Pietra GG; Murciano JC; Shah SA; Ischiropoulos H; Albelda SM; Muzykantov VR
Am J Pathol; 2002 Mar; 160(3):1155-69. PubMed ID: 11891211
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between inflammation and thrombosis.
Esmon CT
Maturitas; 2004 Apr; 47(4):305-14. PubMed ID: 15063484
[TBL] [Abstract][Full Text] [Related]
19. Studies on coagulation incompatibilities for xenotransplantation.
Bulato C; Radu C; Simioni P
Methods Mol Biol; 2012; 885():71-89. PubMed ID: 22565991
[TBL] [Abstract][Full Text] [Related]
20. Prothrombotic Effect of Anti-beta-2 Glycoprotein-1 Antibodies on the Expression of Tissue Factor, Thrombomodulin, and Plasminogen Activator Inhibitor-1 in Endothelial Cells.
Rikarni ; Dharma R; Tambunan KL; Isbagyo H; Dewi BE; Acang N; Setiabudy R; Aman AK
Acta Med Indones; 2015 Jan; 47(1):31-7. PubMed ID: 25948765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
